Search Results - "GASPARETTO, Christina"

Analysis of Common Eligibility Criteria of Randomized Controlled Trials in Newly Diagnosed Multiple Myeloma Patients and Extrapolating Outcomes by Shah, Jatin J., MD, Abonour, Rafat, MD, Gasparetto, Christina, MD, Hardin, James W., PhD, Toomey, Kathleen, MD, Narang, Mohit, MD, Srinivasan, Shankar, PhD, Kitali, Amani, MPH, Zafar, Faiza, MPAS, Flick, E. Dawn, PhD, Rifkin, Robert M., MD

“…Abstract background The performance of multiple myeloma (MM) therapies in a general patient population and specific eligibility criteria that may limit…”
Get full text

P915: TREATMENT PATTERNS AND CLINICAL OUTCOMES OF PATIENTS WITH MULTIPLE MYELOMA PREVIOUSLY TREATED WITH LENALIDOMIDE AND AN ANTI‐CD38 MONOCLONAL ANTIBODY: FINDINGS FROM THE CONNECT MM DISEASE REGISTRY by Abonour, Rafat, Rifkin, Robert, Ailawadhi, Sikander, Lee, Hans C., Gasparetto, Christina, Wagner, Lynne, Durie, Brian, Hardin, James, Terebelo, Howard, Narang, Mohit, Toomey, Kathleen, Tang, Yuexin, Dhanasiri, Sujith, Anand, Jasmeet, Yu, Edward, Marshall, Thomas, Liu, Liang, Jagannath, Sundar

Get full text

Successful allogeneic engraftment of mismatched unrelated cord blood following a nonmyeloablative preparative regimen by Rizzieri, David A., Long, Gwynn D., Vredenburgh, James J., Gasparetto, Christina, Morris, Ashley, Stenzel, Timothy T., Davis, Patti, Chao, Nelson J.

“…Reduction in the toxicity of allogeneic transplantation with nonmyeloablative induction regimens has expanded the scope of practice to older and more…”
Get full text

Phase II Feasibility and Pharmacokinetic Study of Concurrent Administration of Trastuzumab and High-Dose Chemotherapy in Advanced HER2+ Breast Cancer by NIETO, Yago, VREDENBURGH, James J, JONES, Roy B, SHPALL, Elizabeth J, BEARMAN, Scott I, MCSWEENEY, Peter A, CHAO, Nelson, RIZZIERI, David, GASPARETTO, Christina, MATTHES, Steve, BARON, Anna E

“…Purpose: To evaluate the safety of concurrent treatment with trastuzumab and high-dose chemotherapy (HDC), using cyclophosphamide, cisplatin, and…”
Get full text

Phase I Evaluation of Prolonged-infusion Gemcitabine with Fludarabine for Relapsed or Refractory Acute Myelogenous Leukemia by RIZZIERI, David A, IBOM, Valerie K, GASPARETTO, Christina, LONG, Gwynn D, CHAO, Nelson J, GOCKERMAN, Jon P, MOORE, Joseph O, DECASTRO, Carlos M, ROSNER, Gary L, ADAMS, David J, FOSTER, Traci, PAYNE, Nancy, THOMPSON, Maria, VREDENBURGH, James J

“…Purpose: The purpose of this study was to determine the maximum tolerated duration of infusion of gemcitabine at 10 mg/m 2 /min in combination with fludarabine…”
Get full text

Autologous/Allogeneic Hematopoietic Cell Transplantation versus Tandem Autologous Transplantation for Multiple Myeloma: Comparison of Long-Term Postrelapse Survival by Htut, Myo, D'Souza, Anita, Krishnan, Amrita, Bruno, Benedetto, Zhang, Mei-Jie, Fei, Mingwei, Diaz, Miguel Angel, Copelan, Edward, Ganguly, Siddhartha, Hamadani, Mehdi, Kharfan-Dabaja, Mohamed, Lazarus, Hillard, Lee, Cindy, Meehan, Kenneth, Nishihori, Taiga, Saad, Ayman, Seo, Sachiko, Ramanathan, Muthalagu, Usmani, Saad Z., Gasparetto, Christina, Mark, Tomer M., Nieto, Yago, Hari, Parameswaran

“…We compared postrelapse overall survival (OS) after autologous/allogeneic (auto/allo) versus tandem autologous (auto/auto) hematopoietic cell transplantation…”
Get full text

Overcoming Drug Resistance in Mantle Cell Lymphoma Using a Combination of Dose-Dense and Intense Therapy by Crout, Christopher A., Koh, Liang-Piu, Gockerman, Jon P., Moore, Joseph O., DeCastro, Carlos, Long, Gwynn D., Diehl, Louis, Gasparetto, Christina, Niedzwiecki, Donna, Edwards, Jon, Prosnitz, Leonard, Horwitz, Mitchell, Chute, Jon, Morris, Ashley, Davis, Patricia, Beaven, Anne, Chao, Nelson J., Ali-Osman, Francis, Rizzieri, David A.

“…ABSTRACT We present a study of the prevalence of genetic polymorphisms and expression of genes encoding the drug-resistance proteins glutathione S-transferases…”
Get full text

Autologous/Allogeneic Hematopoietic Cell Transplantation (HCT) Versus Tandem Autologous Transplantation for Multiple Myeloma – Comparison of Long Term Post Relapse Survival by Htut, Myo, D’Souza, Anita, Krishnan, Amrita, Bruno, Benedetto, Zhang, Mei-Jie, Fei, Mingwei, Diaz, Miguel Angel, Copelan, Edward, Ganguly, Siddhartha, Hamadani, Mehdi, Kharfan-Dabaja, Mohamed, Lazarus, Hillard, Lee, Cindy, Meehan, Kenneth, Nishihori, Taiga, Saad, Ayman, Seo, Sachiko, Ramanathan, Muthalagu, Usmani, Saad Z., Gasparetto, Christina, Mark, Tomer M., Nieto, Yago, Hari, Parameswaran

“…We compared post-relapse overall survival (OS) after autologous-allogenenic (auto/allo) versus tandem autologous (auto/auto) hematopoietic cell transplantation…”
Get full text

Effects of interleukin-3 on hematopoietic recovery after 5-fluorouracil or cyclophosphamide treatment of cynomolgus primates by GIILLIO, A. P, GASPERETTO, C, LAVER, J, ABBOUD, M, BONILLA, M. A, GARNICK, M. B, O'REILLY, R. J

“…Interleukin-3 (IL-3) is a hematopoietic growth factor that supports the growth of early hematopoietic progenitors in vitro. In vivo administration of…”
Get full text

Autologous Bone Marrow Transplantation in Acute Myelogenous Leukemia: In Vitro Treatment With Myeloid-Specific Monoclonal Antibodies and Drugs in Combination by Lemoli, Roberto M., Gasparetto, Christina, Scheinberg, David A., Moore, Malcom A.S., Clarkson, Bayard D., Gulati, Subhash C.

“…We report the results of a preclinical study comparing four different purging protocols using a promyelocytic human cell line HL-60 and myeloid leukemic…”
Get full text

4-Hydroperoxycyclophosphamide–purged peripheral blood stem cells for autologous transplantation in patients with acute myeloid leukemia by Rizzieri, David A., Talbot, Jeffrey T., Long, Gwynn D., Vredenburgh, James J., Gasparetto, Christina, Smith, Clayton S., Colvin, Michael O., Adams, David, Morris, Ashley, Dodge, Richard, Loftis, Jennifer, Waters-Pick, Barbara, Reese, Melissa, Carawan, Helen, Koh, Liang Piu, Chao, Nelson J.

“…We have performed a phase I dose escalation of 4-Hydroperoxycyclophosphamide (4HC) purging of autologous peripheral blood progenitor cells (PBPCs) to improve…”
Get full text

4-Hydroperoxycyclophosphamide[ndash ]purged peripheral blood stem cells for autologous transplantation in patients with acute myeloid leukemia by Rizzieri, David A., Talbot, Jeffrey T., Long, Gwynn D., Vredenburgh, James J., Gasparetto, Christina, Smith, Clayton S., Colvin, Michael O., Adams, David, Morris, Ashley, Dodge, Richard, Loftis, Jennifer, Waters-Pick, Barbara, Reese, Melissa, Carawan, Helen, Koh, Liang Piu, Chao, Nelson J.

“…Abstract only…”
Get full text